Skip to main content
Image coming soon

Compliance-Ready AI in Pharmaceutical R&D Operations for Compliance Officers

$199.00
Adding to cart… The item has been added

A tailored course, built for your situation

Compliance-Ready AI in Pharmaceutical R&D Operations for Compliance Officers

Master the implementation of AI systems that meet strict compliance standards in drug development environments

$199 one-time
24-hour access provisioning 30-day money-back guarantee Hand-built implementation playbook
12 modules. 12 chapters per module. 144 chapters total.
12 modules, each with 12 chapters (144 chapters total), text-based, plus downloadable templates and a hand-built implementation playbook delivered alongside course access.
Compliance officers face increasing pressure to validate AI-driven R&D processes without clear frameworks or operational tools.

The situation this course is for

AI adoption in pharmaceutical research is accelerating, but compliance teams lack structured, implementable guidance to assess, monitor, and govern these systems within GxP, FDA 21 CFR Part 11, and EMA Annex 11 environments. This gap slows innovation and increases review cycle times.

Who this is for

Compliance, quality assurance, and regulatory affairs professionals in pharmaceutical or biotech organizations overseeing R&D processes involving AI or planning to do so.

Who this is not for

This course is not for data scientists focused purely on model development, nor for executives seeking high-level AI strategy without implementation detail.

What you walk away with

  • Apply compliance-by-design principles to AI systems in preclinical and clinical development
  • Map AI workflows to current GxP, ALCOA+, and data integrity requirements
  • Build audit-ready documentation packages for AI-augmented R&D activities
  • Coordinate cross-functionally with data science, QA, and regulatory teams using standardized protocols
  • Anticipate and address regulatory inspection points specific to AI in drug development

The 12 modules (with all 144 chapters)

Module 1. Foundations of AI in Regulated R&D
Understand the technical and regulatory landscape shaping AI adoption in pharmaceutical development.
12 chapters in this module
  1. Introduction to AI in drug discovery and development
  2. Key regulatory bodies and their AI guidance frameworks
  3. Differentiating AI, ML, and automation in R&D contexts
  4. Compliance officer roles in AI governance
  5. Core principles of data integrity in AI systems
  6. Overview of GxP applicability to AI workflows
  7. Risk-based approach to AI validation
  8. Stakeholder mapping in AI projects
  9. Lifecycle view of AI in R&D
  10. Common misconceptions about AI compliance
  11. Regulatory trends shaping AI adoption
  12. Course navigation and implementation playbook overview
Module 2. Regulatory Frameworks and AI Alignment
Map global compliance requirements to AI system design and operation.
12 chapters in this module
  1. FDA AI/ML Software as a Medical Device action plan
  2. EMA perspective on AI in medicinal product development
  3. ICH guidelines relevant to AI-driven data analysis
  4. 21 CFR Part 11 and electronic records in AI systems
  5. Annex 11 and computerized systems validation for AI
  6. GDPR and patient data in AI training sets
  7. ISO 13485 and quality management for AI
  8. Aligning AI outputs with regulatory submission standards
  9. Inspection readiness for AI-augmented processes
  10. Labeling considerations for AI-influenced products
  11. Post-market surveillance and AI model updates
  12. Gap analysis between AI capabilities and current regulations
Module 3. AI System Validation for Compliance
Implement rigorous validation protocols tailored to adaptive AI systems.
12 chapters in this module
  1. Validation lifecycle for machine learning models
  2. Defining user requirements for AI in R&D
  3. Risk assessment using GAMP 5 principles
  4. Developing test strategies for non-deterministic systems
  5. Version control and reproducibility in AI models
  6. Establishing performance benchmarks and thresholds
  7. Validation of training, validation, and test datasets
  8. Handling model drift and revalidation triggers
  9. Audit trail requirements for AI decision paths
  10. Change control processes for model updates
  11. Documentation standards for AI validation reports
  12. Leveraging templates for efficient validation
Module 4. Data Integrity and AI
Ensure AI systems uphold ALCOA+ principles throughout the data lifecycle.
12 chapters in this module
  1. Applying ALCOA+ to AI-generated and AI-processed data
  2. Data provenance and lineage in complex pipelines
  3. Ensuring data completeness and consistency
  4. Preventing unauthorized data manipulation
  5. Role-based access control in AI environments
  6. Audit trail design for AI model interactions
  7. Data anonymization and privacy-preserving techniques
  8. Handling missing data in AI training sets
  9. Data quality metrics for compliance reporting
  10. Validation of data preprocessing steps
  11. Storage and retention of AI-relevant datasets
  12. Cross-system data synchronization challenges
Module 5. Compliance-by-Design Methodology
Embed regulatory requirements into AI system architecture from inception.
12 chapters in this module
  1. Principles of compliance-by-design in AI
  2. Integrating regulatory input during project scoping
  3. Designing for auditability and transparency
  4. Building in explainability without sacrificing performance
  5. Selecting compliant cloud and infrastructure providers
  6. Ensuring model interpretability for regulators
  7. Designing human-in-the-loop decision pathways
  8. Fail-safe mechanisms for AI recommendations
  9. Documentation requirements at each design stage
  10. Stakeholder alignment workshops for compliance goals
  11. Using design sprints to validate regulatory alignment
  12. Case study: compliance-by-design in a drug discovery AI
Module 6. AI Risk Assessment and Management
Conduct structured risk evaluations for AI applications in regulated R&D.
12 chapters in this module
  1. Risk identification specific to AI in pharmaceutical contexts
  2. Using FMEA for AI system components
  3. Assessing patient safety implications of AI outputs
  4. Data bias and fairness in drug development models
  5. Model uncertainty and confidence interval reporting
  6. Third-party AI vendor risk assessment
  7. Supply chain risks in AI model dependencies
  8. Cybersecurity considerations for AI systems
  9. Business continuity planning for AI outages
  10. Risk register development and maintenance
  11. Escalation pathways for high-risk findings
  12. Reporting risk assessments to quality units
Module 7. Audit and Inspection Readiness
Prepare for regulatory scrutiny of AI-augmented R&D processes.
12 chapters in this module
  1. Common inspection questions about AI systems
  2. Preparing AI documentation for auditor review
  3. Demonstrating validation and revalidation history
  4. Responding to queries about model performance
  5. Presenting data integrity controls for AI workflows
  6. Handling requests for model source code or logic
  7. Conducting internal audits of AI projects
  8. Mock inspection exercises for AI compliance
  9. Training auditors on AI concepts and limitations
  10. Maintaining inspection response playbooks
  11. Post-inspection follow-up and CAPA integration
  12. Using audit findings to improve AI governance
Module 8. Change Control and AI Model Updates
Manage AI system evolution within compliance frameworks.
12 chapters in this module
  1. Triggers for AI model revalidation
  2. Change control documentation for model updates
  3. Versioning strategies for AI models and datasets
  4. Impact assessment of algorithm modifications
  5. Re-testing requirements after updates
  6. Rollback procedures for failed AI updates
  7. Communication plans for AI changes
  8. Managing model drift detection and response
  9. Scheduled revalidation cycles
  10. Change logs and audit trail maintenance
  11. Coordination with IT and data science teams
  12. Regulatory reporting obligations for significant changes
Module 9. Cross-Functional Collaboration Models
Lead effective collaboration between compliance, data science, and R&D teams.
12 chapters in this module
  1. Building shared vocabulary across disciplines
  2. Establishing governance committees for AI projects
  3. Facilitating compliance input in agile development
  4. Translating regulatory requirements for technical teams
  5. Creating feedback loops between QA and data science
  6. Joint risk assessment workshops
  7. Conflict resolution in AI compliance disputes
  8. Scheduling alignment checkpoints in project timelines
  9. Documenting cross-functional decisions
  10. Role clarification in AI project teams
  11. Training non-compliance staff on regulatory basics
  12. Measuring collaboration effectiveness
Module 10. Vendor and Third-Party Management
Ensure external AI providers meet pharmaceutical compliance standards.
12 chapters in this module
  1. Due diligence for AI software vendors
  2. Evaluating third-party model validation evidence
  3. Contractual requirements for AI compliance
  4. Auditing external AI development practices
  5. Data processing agreements for cloud AI services
  6. Assessing vendor change control processes
  7. Managing open-source AI component risks
  8. Vendor performance monitoring and KPIs
  9. Exit strategies and data portability
  10. Ensuring vendor inspection readiness
  11. Handling vendor non-conformances
  12. Maintaining oversight of outsourced AI functions
Module 11. AI in Clinical Trial Design and Monitoring
Apply compliance frameworks to AI applications in clinical research.
12 chapters in this module
  1. AI for patient recruitment and site selection
  2. Compliance considerations in predictive enrollment models
  3. AI in adverse event detection and reporting
  4. Monitoring protocol deviations using machine learning
  5. Ensuring ICH GCP compliance in AI-augmented trials
  6. Data privacy in decentralized trial AI tools
  7. Validation of AI tools for endpoint analysis
  8. Regulatory expectations for AI in adaptive trials
  9. Audit trails for AI-driven monitoring decisions
  10. Blinding and unblinding procedures with AI
  11. Training clinical staff on AI-assisted workflows
  12. Reporting AI use in clinical study reports
Module 12. Future-Proofing AI Compliance Strategy
Anticipate emerging requirements and lead ongoing AI governance evolution.
12 chapters in this module
  1. Tracking global regulatory developments in AI
  2. Participating in industry working groups
  3. Building internal AI governance policies
  4. Developing AI compliance training programs
  5. Creating centers of excellence for AI assurance
  6. Benchmarking against peer organizations
  7. Investing in compliance automation tools
  8. Succession planning for AI oversight roles
  9. Measuring ROI of AI compliance initiatives
  10. Communicating AI compliance value to leadership
  11. Adapting to new technical standards
  12. Course wrap-up and implementation playbook integration

How this maps to your situation

  • Implementing AI in preclinical research settings
  • Validating machine learning models for clinical data analysis
  • Preparing for regulatory submission involving AI-derived insights
  • Managing third-party AI vendors in drug development

Before vs. after

Before
Uncertainty about how to apply compliance frameworks to adaptive AI systems, leading to delayed projects and increased inspection risk.
After
Confidence in guiding AI implementation with clear, auditable processes that satisfy regulatory expectations and accelerate innovation.

What's included with your purchase

  • 12 modules with 12 chapters each (144 chapters)
  • Downloadable templates and worked examples for every module
  • Hand-built implementation playbook delivered alongside course access
  • 30-day money-back guarantee

Delivery and format

  • Course and learning environment access provisioned within 24 hours of purchase
  • Hand-built implementation playbook delivered alongside course access

Format: Text-based modules and chapters in the Art of Service learning environment, plus downloadable templates and worked examples for every chapter, plus the hand-built implementation playbook delivered alongside course access.

Time investment: Approximately 45, 60 hours of self-paced learning, designed to fit around professional responsibilities.

If nothing changes
Continuing without structured AI compliance knowledge may result in rejected submissions, inspection findings, or project delays due to last-minute validation efforts.

How this compares to the alternatives

Unlike generic AI ethics courses or high-level strategy talks, this program delivers specific, implementable compliance protocols for pharmaceutical R&D, actionable from day one.

Frequently asked

Who is this course designed for?
Compliance officers, quality assurance leads, and regulatory affairs professionals in pharmaceutical or biotech organizations involved in AI-augmented R&D.
How is the course structured?
12 modules, each containing 12 chapters (144 chapters total).
Is this course technical or regulatory?
It bridges both domains, providing regulatory depth with technical context to enable effective oversight of AI systems in drug development.
$199 one-time. Approximately 45, 60 hours of self-paced learning, designed to fit around professional responsibilities..

Within 24 hours your account in the learning environment is provisioned and the tailored implementation playbook is delivered alongside it.

30-day money-back guarantee· 144 chapters· Hand-built playbook included· Account access within 24 hours
!